C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells

Jamie D. Gardiner, Lisa M. Abegglen, Xiaomeng Huang, Bryce E. Carter, Elizabeth A. Schackmann, Marcus Stucki, Christian N. Paxton, R Randall, James F. Amatruda, Angelica R. Putnam, Heinrich Kovar, Stephen L. Lessnick, Joshua D. Schiffman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

CEBPB copy number gain in Ewing sarcoma was previously shown to be associated with worse clinical outcome compared to tumors with normal CEBPB copy number, although the mechanism was not characterized. We employed gene knockdown and rescue assays to explore the consequences of altered CEBPB gene expression in Ewing sarcoma cell lines. Knockdown of EWS-FLI1 expression led to a decrease in expression of all three C/EBPβ isoforms while re-expression of EWS-FLI1 rescued C/EBPβ expression. Overexpression of C/EBPβ-1, the largest of the three C/EBPβ isoforms, led to a significant increase in colony formation when cells were grown in soft agar compared to empty vector transduced cells. In addition, depletion of C/EBPβ decreased colony formation, and re-expression of either C/EBPβ-1 or C/EBPβ-2 rescued the phenotype. We identified the cancer stem cell marker ALDH1A1 as a target of C/EBPβ in Ewing sarcoma. Furthermore, increased expression of C/EBPβ led to resistance to chemotherapeutic agents. In summary, we have identified CEBPB as an oncogene in Ewing sarcoma. Overexpression of C/EBPβ-1 increases transformation, upregulates expression of the cancer stem cell marker ALDH1A1, and leads to chemoresistance.

Original languageEnglish (US)
Pages (from-to)26013-26026
Number of pages14
JournalOncotarget
Volume8
Issue number16
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Ewing's Sarcoma
Neoplastic Stem Cells
Protein Isoforms
Gene Knockdown Techniques
Oncogenes
Agar
Up-Regulation
Phenotype
Gene Expression
Cell Line
Neoplasms
EWS-FLI fusion protein

Keywords

  • ALDH1A1
  • Biomarker
  • C/EBPβ
  • Chemoresistance
  • Ewing sarcoma

ASJC Scopus subject areas

  • Oncology

Cite this

Gardiner, J. D., Abegglen, L. M., Huang, X., Carter, B. E., Schackmann, E. A., Stucki, M., ... Schiffman, J. D. (2017). C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget, 8(16), 26013-26026. https://doi.org/10.18632/oncotarget.14847

C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells. / Gardiner, Jamie D.; Abegglen, Lisa M.; Huang, Xiaomeng; Carter, Bryce E.; Schackmann, Elizabeth A.; Stucki, Marcus; Paxton, Christian N.; Randall, R; Amatruda, James F.; Putnam, Angelica R.; Kovar, Heinrich; Lessnick, Stephen L.; Schiffman, Joshua D.

In: Oncotarget, Vol. 8, No. 16, 01.01.2017, p. 26013-26026.

Research output: Contribution to journalArticle

Gardiner, JD, Abegglen, LM, Huang, X, Carter, BE, Schackmann, EA, Stucki, M, Paxton, CN, Randall, R, Amatruda, JF, Putnam, AR, Kovar, H, Lessnick, SL & Schiffman, JD 2017, 'C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells', Oncotarget, vol. 8, no. 16, pp. 26013-26026. https://doi.org/10.18632/oncotarget.14847
Gardiner JD, Abegglen LM, Huang X, Carter BE, Schackmann EA, Stucki M et al. C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget. 2017 Jan 1;8(16):26013-26026. https://doi.org/10.18632/oncotarget.14847
Gardiner, Jamie D. ; Abegglen, Lisa M. ; Huang, Xiaomeng ; Carter, Bryce E. ; Schackmann, Elizabeth A. ; Stucki, Marcus ; Paxton, Christian N. ; Randall, R ; Amatruda, James F. ; Putnam, Angelica R. ; Kovar, Heinrich ; Lessnick, Stephen L. ; Schiffman, Joshua D. / C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells. In: Oncotarget. 2017 ; Vol. 8, No. 16. pp. 26013-26026.
@article{1233d4b53ecc4d03b042211d0550f2da,
title = "C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells",
abstract = "CEBPB copy number gain in Ewing sarcoma was previously shown to be associated with worse clinical outcome compared to tumors with normal CEBPB copy number, although the mechanism was not characterized. We employed gene knockdown and rescue assays to explore the consequences of altered CEBPB gene expression in Ewing sarcoma cell lines. Knockdown of EWS-FLI1 expression led to a decrease in expression of all three C/EBPβ isoforms while re-expression of EWS-FLI1 rescued C/EBPβ expression. Overexpression of C/EBPβ-1, the largest of the three C/EBPβ isoforms, led to a significant increase in colony formation when cells were grown in soft agar compared to empty vector transduced cells. In addition, depletion of C/EBPβ decreased colony formation, and re-expression of either C/EBPβ-1 or C/EBPβ-2 rescued the phenotype. We identified the cancer stem cell marker ALDH1A1 as a target of C/EBPβ in Ewing sarcoma. Furthermore, increased expression of C/EBPβ led to resistance to chemotherapeutic agents. In summary, we have identified CEBPB as an oncogene in Ewing sarcoma. Overexpression of C/EBPβ-1 increases transformation, upregulates expression of the cancer stem cell marker ALDH1A1, and leads to chemoresistance.",
keywords = "ALDH1A1, Biomarker, C/EBPβ, Chemoresistance, Ewing sarcoma",
author = "Gardiner, {Jamie D.} and Abegglen, {Lisa M.} and Xiaomeng Huang and Carter, {Bryce E.} and Schackmann, {Elizabeth A.} and Marcus Stucki and Paxton, {Christian N.} and R Randall and Amatruda, {James F.} and Putnam, {Angelica R.} and Heinrich Kovar and Lessnick, {Stephen L.} and Schiffman, {Joshua D.}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.14847",
language = "English (US)",
volume = "8",
pages = "26013--26026",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "16",

}

TY - JOUR

T1 - C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells

AU - Gardiner, Jamie D.

AU - Abegglen, Lisa M.

AU - Huang, Xiaomeng

AU - Carter, Bryce E.

AU - Schackmann, Elizabeth A.

AU - Stucki, Marcus

AU - Paxton, Christian N.

AU - Randall, R

AU - Amatruda, James F.

AU - Putnam, Angelica R.

AU - Kovar, Heinrich

AU - Lessnick, Stephen L.

AU - Schiffman, Joshua D.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - CEBPB copy number gain in Ewing sarcoma was previously shown to be associated with worse clinical outcome compared to tumors with normal CEBPB copy number, although the mechanism was not characterized. We employed gene knockdown and rescue assays to explore the consequences of altered CEBPB gene expression in Ewing sarcoma cell lines. Knockdown of EWS-FLI1 expression led to a decrease in expression of all three C/EBPβ isoforms while re-expression of EWS-FLI1 rescued C/EBPβ expression. Overexpression of C/EBPβ-1, the largest of the three C/EBPβ isoforms, led to a significant increase in colony formation when cells were grown in soft agar compared to empty vector transduced cells. In addition, depletion of C/EBPβ decreased colony formation, and re-expression of either C/EBPβ-1 or C/EBPβ-2 rescued the phenotype. We identified the cancer stem cell marker ALDH1A1 as a target of C/EBPβ in Ewing sarcoma. Furthermore, increased expression of C/EBPβ led to resistance to chemotherapeutic agents. In summary, we have identified CEBPB as an oncogene in Ewing sarcoma. Overexpression of C/EBPβ-1 increases transformation, upregulates expression of the cancer stem cell marker ALDH1A1, and leads to chemoresistance.

AB - CEBPB copy number gain in Ewing sarcoma was previously shown to be associated with worse clinical outcome compared to tumors with normal CEBPB copy number, although the mechanism was not characterized. We employed gene knockdown and rescue assays to explore the consequences of altered CEBPB gene expression in Ewing sarcoma cell lines. Knockdown of EWS-FLI1 expression led to a decrease in expression of all three C/EBPβ isoforms while re-expression of EWS-FLI1 rescued C/EBPβ expression. Overexpression of C/EBPβ-1, the largest of the three C/EBPβ isoforms, led to a significant increase in colony formation when cells were grown in soft agar compared to empty vector transduced cells. In addition, depletion of C/EBPβ decreased colony formation, and re-expression of either C/EBPβ-1 or C/EBPβ-2 rescued the phenotype. We identified the cancer stem cell marker ALDH1A1 as a target of C/EBPβ in Ewing sarcoma. Furthermore, increased expression of C/EBPβ led to resistance to chemotherapeutic agents. In summary, we have identified CEBPB as an oncogene in Ewing sarcoma. Overexpression of C/EBPβ-1 increases transformation, upregulates expression of the cancer stem cell marker ALDH1A1, and leads to chemoresistance.

KW - ALDH1A1

KW - Biomarker

KW - C/EBPβ

KW - Chemoresistance

KW - Ewing sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85017508245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017508245&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.14847

DO - 10.18632/oncotarget.14847

M3 - Article

AN - SCOPUS:85017508245

VL - 8

SP - 26013

EP - 26026

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 16

ER -